Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis
Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis
Not yet recruiting · NCT05647096 · Registry updated 2024-11-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sepsis, Systemic Inflammatory Response Syndrome, respiratory failure, respiratory system disorder | Not yet recruiting | Not applicable | 2024-11-29 | NCT05647096 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ISS AG | 1 |
| Santersus AG | 2 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guy's and St Thomas' Hospital | London | United Kingdom | 2 |
| Hannover Medical School | Hannover | Germany | 1 |
| Liverpool University Hospital | Liverpool | United Kingdom | 2 |
| Queen Elizabeth Hospital Birmingham | Birmingham | United Kingdom | 10 |
| Royal Infirmary of Edinburgh | Edinburgh | United Kingdom | 13 |
| Technical University Dresden | Dresden | Germany | 2 |
| University College London | London | United Kingdom | 14 |
| University of Bonn | Bonn | Germany | 6 |
| University of Zurich | Zurich | Switzerland | 10 |